Newsletter

News of Kasznar Leonardos Intelectual Property, with Offices in RJ, SP and RS – Brazil.

The first Action Plan for the implementation of the National Intellectual Property Strategy is approved

On June 9, 2021, the Interministerial Group on Industrial Property (GIPI, in the Portuguese acronym) approved the first Action Plan for the The first Action Plan for the implementation of the National Intellectual Property Strategy is approved

Special Committee of the Chamber of Deputies approves Bill No. 399/2015, on medical, veterinary and industrial uses of Cannabis

In a tight vote, the Special Committee of the Chamber of Deputies approved this Tuesday, June 8, Bill No. 399/2015 (PL 399/2015), Special Committee of the Chamber of Deputies approves Bill No. 399/2015, on medical, veterinary and industrial uses of Cannabis

Brazilian Data Protection Authority publishes guidelines for controllers, processors and DPOs

Last Friday (May 28), the Brazilian Data Protection Authority (ANPD) published the “Guidelines for Definitions of Data Processing Agents and Data Protection Brazilian Data Protection Authority publishes guidelines for controllers, processors and DPOs

The end of the trial on the term of protection of Patents in Brazil

Modulation of Effects Approved by the Supreme Court   After 10 (ten) sessions debating the matter, on May 12, 2021 the Brazilian The end of the trial on the term of protection of Patents in Brazil

Brazilian Supreme Court decides which is the correct term of protection of patents in Brazil

Invention patents are valid for 20 years from filing, without any extension   On May 06, 2021, the 11 Justices of the Brazilian Supreme Court decides which is the correct term of protection of patents in Brazil

Brazilian Ministry of Health advocates for the end of prior consent for pharmaceutical patents and proposes a new remedy for delays in patent prosecution

The prosecution of the Direct Plea of Unconstitutionality No. 5529 (ADI 5529) before the Supreme Court has been causing an intense debate Brazilian Ministry of Health advocates for the end of prior consent for pharmaceutical patents and proposes a new remedy for delays in patent prosecution

ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

ANVISA’s Board of Directors opened a Public Consultation (“PC 1,039/2021”), available to contributions between 04/15/2021 and 06/15/2021, to discuss a proposed regulation ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

The Term of Patents in Brazil: what a difference a day makes!

Changes in the preliminary injunction granted by the Brazilian Supreme Court   As per our Newsletter No. 7/2021, on April 7th, 2021, The Term of Patents in Brazil: what a difference a day makes!

Judgment Day: the term of Patents in Brazil

Summary: in a judgment initiated on April 7, 2021, the Brazilian Supreme Court decided to immediately suspend the validity of all patents Judgment Day: the term of Patents in Brazil

Brazilian PTO extends the Patent Backlog Fighting Project

Continuing with the goal of reducing the number of patent applications pending decision, the Brazilian PTO (“BPTO”) published the Ordinance/INPI/PR N° 21, Brazilian PTO extends the Patent Backlog Fighting Project